BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R, Ferrozzi F, Corradi D, Salvarani C, Buzio C. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet. 2011;378:338-346. [PMID: 21733570 DOI: 10.1016/s0140-6736(11)60934-3] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 11.4] [Reference Citation Analysis]
Number Citing Articles
1 Kharagjitsing HHS, Hendriksz TR, Fouraux MA, van Gelder T, van Bommel EFH. Clinical significance of soluble interleukin-2 receptor measurement in patients with idiopathic retroperitoneal fibrosis. Int Urol Nephrol 2022. [PMID: 35359217 DOI: 10.1007/s11255-022-03196-3] [Reference Citation Analysis]
2 Yahşi S. A Retroperitoneal Fibrosis Case Presented with Spontaneous Rupture of Renal Pelvis. Indian J Surg. [DOI: 10.1007/s12262-021-03257-4] [Reference Citation Analysis]
3 Li J, Wang H, Wang M, Xu F, Guo F, Ye F. Differences of clinicopathological features between IgG4-related and non-IgG4-related idiopathic retroperitoneal fibrosis. Int J Rheum Dis 2022. [PMID: 35043583 DOI: 10.1111/1756-185X.14287] [Reference Citation Analysis]
4 Kharagjitsing HHS, van Vooren J, Brilman EG, Hendriksz TR, van Gelder T, van Bommel EFH. Abdominal aortic diameter and cardiovascular status in patients with idiopathic retroperitoneal fibrosis. Rheumatol Int 2021. [PMID: 34821970 DOI: 10.1007/s00296-021-05051-7] [Reference Citation Analysis]
5 Mizushima I, Kawano M. Renal Involvement in Retroperitoneal Fibrosis: Prevalence, Impact and Management Challenges. Int J Nephrol Renovasc Dis 2021;14:279-89. [PMID: 34349543 DOI: 10.2147/IJNRD.S239160] [Reference Citation Analysis]
6 Cao S, Meng X, Li Y, Sun L, Jiang L, Xuan H, Chen X. Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages. Front Immunol 2021;12:632864. [PMID: 33968024 DOI: 10.3389/fimmu.2021.632864] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Razanamahery J, Bouldoires B, Humbert S, Bielefeld P, Fournier V, Bonnotte B, Blaison G, Magy-Bertrand N. Characteristics of Adult Patients with Idiopathic Retroperitoneal Fibrosis and Assessment of Risk of Relapse at Diagnosis. J Clin Med 2021;10:1380. [PMID: 33808093 DOI: 10.3390/jcm10071380] [Reference Citation Analysis]
8 Pacella JC, Niwattisaiwong S, Newman D. IgG4-Related Retroperitoneal Fibrosis: A Rare Association With Riedel's Thyroiditis. Cureus 2021;13:e13997. [PMID: 33884241 DOI: 10.7759/cureus.13997] [Reference Citation Analysis]
9 Wang K, Wang Z, Zeng Q, Zhu L, Gao J, Wang Z, Zhang S, Yang F, Shen D, Wang Y, Liu Y. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis. PLoS One 2021;16:e0245601. [PMID: 33600452 DOI: 10.1371/journal.pone.0245601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Boyeva V, Alabsi H, Seidman MA, Paterson R, Kur J, Chen LYC, Chang SD, Carruthers M. Use of rituximab in idiopathic retroperitoneal fibrosis. BMC Rheumatol 2020;4:40. [PMID: 32775962 DOI: 10.1186/s41927-020-00140-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Roussel E, Callemeyn J, Van Moerkercke W. Standardized approach to idiopathic retroperitoneal fibrosis: a comprehensive review of the literature. Acta Clin Belg 2020;75:239-44. [PMID: 31035909 DOI: 10.1080/17843286.2019.1609152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Meijer EF, Bouta EM, Mendonca C, Skolny MN, Salama LW, Taghian AG, Padera TP. A retrospective analysis of commonly prescribed medications and the risk of developing breast cancer related lymphedema. Clin Res Trials 2020;6. [PMID: 32864167 DOI: 10.15761/crt.1000293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kirby DT, Dilday JC, Muir KB, Young AG, Aidinian G. Inferior vena cava occlusion in retroperitoneal fibrosis and exogenous testosterone administration. J Vasc Surg Cases Innov Tech 2020;6:34-7. [PMID: 32083233 DOI: 10.1016/j.jvscit.2019.07.010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Trinder M, Mwipatayi BP, Siew T, Lim A, Altaf N. Novel Management of Peri-Aortitis after Endovascular Repair of Abdominal Aortic Aneurysm. EJVES Short Rep 2019;45:34-7. [PMID: 31872087 DOI: 10.1016/j.ejvssr.2019.10.002] [Reference Citation Analysis]
15 Moriconi D, Giannese D, Capecchi R, Cupisti A, Barsotti S, Morganti R, Orsitto E, Gaetano Tavoni A, Francesca Egidi M. Risk factors for relapse and long-term outcome of idiopathic retroperitoneal fibrosis. Clin Exp Nephrol 2019;23:1147-53. [PMID: 31230189 DOI: 10.1007/s10157-019-01759-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
16 Rehman M, Vodret S, Braga L, Guarnaccia C, Celsi F, Rossetti G, Martinelli V, Battini T, Long C, Vukusic K, Kocijan T, Collesi C, Ring N, Skoko N, Giacca M, Del Sal G, Confalonieri M, Raspa M, Marcello A, Myers MP, Crovella S, Carloni P, Zacchigna S. High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation. JCI Insight 2019;4:123987. [PMID: 30996132 DOI: 10.1172/jci.insight.123987] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
17 Maritati F, Rocco R, Accorsi Buttini E, Marvisi C, Nicastro M, Urban ML, Fenaroli P, Peyronel F, Benigno GD, Palumbo AA, Corradi D, Emmi G, Pipitone N, Palmisano A, Vaglio A. Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients. Front Immunol 2019;10:693. [PMID: 31019511 DOI: 10.3389/fimmu.2019.00693] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
18 Nguyen TV, Bader NM, Sidhu H, Cadacio C, Mendoza SM, Pham PTT, Pham PCT. Acute Kidney Failure in a Young African American Male. Case Rep Nephrol 2019;2019:2591560. [PMID: 30911422 DOI: 10.1155/2019/2591560] [Reference Citation Analysis]
19 Sharma S, Paniagua-Morales JA, Cordoba GG, Then EO, Sharma S. Idiopathic Retroperitoneal Fibrosis Presenting as Low Back Pain. Cureus 2019;11:e4075. [PMID: 31019853 DOI: 10.7759/cureus.4075] [Reference Citation Analysis]
20 Mzabi A, Kéchrid N, Alaya Z, Rezgui A, Ben Fredj F, Bouajina E, Laouani C. [Retroperitoneal fibrosis in adults: Diagnostic approach based on a retrospective multicenter study on 32 cases]. Prog Urol 2019;29:76-85. [PMID: 30579757 DOI: 10.1016/j.purol.2018.10.006] [Reference Citation Analysis]
21 Ur Rahman A, Ramaraj R, Humphreys E, Slowinska E. Retroperitoneal Fibrosis as a Cause of Chylous Ascites. ACG Case Rep J 2017;4:e115. [PMID: 29090239 DOI: 10.14309/crj.2017.115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Yamakawa H, Sekine A, Yamanaka Y, Sadoyama S, Baba T, Hagiwara E, Okudela K, Ogura T. Pathologically Proven Spontaneous Remission of IgG4-related Retroperitoneal Fibrosis. Intern Med 2017;56:1867-71. [PMID: 28717084 DOI: 10.2169/internalmedicine.56.7996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
23 Terzic B, Spasic M, Djuric P, Vasiljevic V, Radjen S, Mijuskovic M. Retroperitoneal fibrosis and constrictive pericarditis-IgG4 related diseases: A case report. Exp Ther Med 2017;13:3603-6. [PMID: 28588687 DOI: 10.3892/etm.2017.4425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Jakhlal N, Elghazoui A, Jabbour Y, Karmouni T, Elkhader K, Koutani A, Ibenattya A. Fibrose rétropéritonéale: revue de littérature. Can Urol Assoc J 2017;11:E26-31. [PMID: 28163809 DOI: 10.5489/cuaj.4122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
25 Rossi GM, Rocco R, Accorsi Buttini E, Marvisi C, Vaglio A. Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease. Intern Emerg Med 2017;12:287-99. [DOI: 10.1007/s11739-016-1599-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
26 Runowska M, Majewski D, Puszczewicz M. Retroperitoneal fibrosis - the state-of-the-art. Reumatologia 2016;54:256-63. [PMID: 27994271 DOI: 10.5114/reum.2016.63667] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
27 Laroche AS, Bell RZ, Bezzaoucha S, Földes E, Lamarche C, Vallée M. Retroperitoneal fibrosis: retrospective descriptive study on clinical features and management. Res Rep Urol 2016;8:175-9. [PMID: 27822461 DOI: 10.2147/RRU.S115448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
28 Maritati F, Iannuzzella F, Pavia MP, Pasquali S, Vaglio A. Kidney involvement in medium- and large-vessel vasculitis. J Nephrol 2016;29:495-505. [PMID: 27098921 DOI: 10.1007/s40620-016-0303-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
29 Jarosch A, Tiller M, Rohrbach H, Leimbach T, Schepp W. [Secondary retroperitoneal fibrosis in a 39-year-old man after rectal cancer]. Internist (Berl) 2016;57:495-501. [PMID: 26895316 DOI: 10.1007/s00108-016-0025-y] [Reference Citation Analysis]
30 Vaglio A, Maritati F. Idiopathic Retroperitoneal Fibrosis. J Am Soc Nephrol 2016;27:1880-9. [PMID: 26860343 DOI: 10.1681/ASN.2015101110] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 9.8] [Reference Citation Analysis]
31 van der Bilt FE, Hendriksz TR, van der Meijden WA, Brilman LG, van Bommel EF. Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy. Clin Kidney J 2016;9:184-91. [PMID: 26985367 DOI: 10.1093/ckj/sfv148] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
32 Zhou HJ, Yan Y, Zhou B, Lan TF, Wang XY, Li CS. Retroperitoneal fibrosis: a retrospective clinical data analysis of 30 patients in a 10-year period. Chin Med J (Engl) 2015;128:804-10. [PMID: 25758277 DOI: 10.4103/0366-6999.152648] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
33 Siegmund B. Medical Therapy of Fibrostenotic Crohn's Disease. Viszeralmedizin 2015;31:259-64. [PMID: 26557834 DOI: 10.1159/000435868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Yachoui R, Sehgal R, Carmichael B. Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis. Clin Rheumatol 2016;35:401-7. [PMID: 26208444 DOI: 10.1007/s10067-015-3022-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
35 Yalcin MU, Gurses KM, Kocyigit D, Yorgun H, Aytemir K. Wrapped coronary arteries: a rare manifestation of retroperitoneal fibrosis. Int J Rheum Dis 2015;18:913-6. [PMID: 26176789 DOI: 10.1111/1756-185X.12715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Wilson MW, Milks MW. Acute renal vein thrombosis and nephrotic syndrome in the setting of retroperitoneal fibrosis. Oxf Med Case Reports 2015;2015:309-10. [PMID: 26421156 DOI: 10.1093/omcr/omv043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Cristian S, Cristian M, Cristian P, Constantin G, Savu C, Huri E, Sinescu I. Management of idiopathic retroperitoneal fibrosis from the urologist's perspective. Ther Adv Urol 2015;7:85-99. [PMID: 25829952 DOI: 10.1177/1756287214565637] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
38 Nichols HB, DeRoo LA, Scharf DR, Sandler DP. Risk-benefit profiles of women using tamoxifen for chemoprevention. J Natl Cancer Inst 2015;107:354. [PMID: 25475563 DOI: 10.1093/jnci/dju354] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
39 Hara N, Kawaguchi M, Takeda K, Zen Y. Retroperitoneal disorders associated with IgG4-related autoimmune pancreatitis. World J Gastroenterol 2014; 20(44): 16550-16558 [PMID: 25469023 DOI: 10.3748/wjg.v20.i44.16550] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
40 Tritschler T, Bleisch J, Al Rifai A, Marques Maggio E, Müller S, Schorn R. [Subacute lower back pain and acute kidney failure in a 47-year old man]. Internist (Berl) 2014;55:1094, 1096-9. [PMID: 25120027 DOI: 10.1007/s00108-014-3525-7] [Reference Citation Analysis]
41 Bettenworth D, Rieder F. Medical therapy of stricturing Crohn’s disease: what the gut can learn from other organs - a systematic review. Fibrogenesis Tissue Repair. 2014;7:5. [PMID: 24678903 DOI: 10.1186/1755-1536-7-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
42 Kim BS, Lee WK, Choi HM, Seong CS, Lee HS, Kim JG, Kim MW, Lee KY, Sun IO. Idiopathic retroperitoneal fibrosis associated with Hashimoto's thyroiditis in a patient with a single functioning kidney. Kidney Res Clin Pract 2013;32:183-5. [PMID: 26877939 DOI: 10.1016/j.krcp.2013.08.003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Schirmer JH, Both M, Moosig F. [Chronic periaortitis]. Internist (Berl) 2013;54:1419-20, 1422, 1424-6. [PMID: 24253388 DOI: 10.1007/s00108-013-3297-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Niccoli Asabella A, Nicoletti A, Altini C, Notaristefano A, Lastilla G, Rubini G. 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnosis and Post-Therapeutic Treatment in a Patient with an Early Stage of Retroperitoneal Fibrosis. Mol Imaging Radionucl Ther 2013;22:60-2. [PMID: 24003399 DOI: 10.4274/Mirt.140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
45 Williams G, Sarkar B, Neilly JB, McKay GA. Spontaneous remission in a case of idiopathic retroperitoneal fibrosis. Scott Med J 2013;58:e7-9. [PMID: 23728768 DOI: 10.1177/0036933012474607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
46 Monach PA. IgG4-related Disease: 2013 Update. Curr Treat Options Cardiovasc Med 2013;15:214-23. [PMID: 23392964 DOI: 10.1007/s11936-013-0232-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Brandt AS, Kamper L, Kukuk S, Piroth W, Haage P, Roth S. An aid to decision-making in therapy of retroperitoneal fibrosis: dynamic enhancement analysis of gadolinium MRI. J Clin Med Res 2013;5:49-56. [PMID: 23390476 DOI: 10.4021/jocmr1254e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
48 Fujimori N, Ito T, Igarashi H, Oono T, Nakamura T, Niina Y, Hijioka M, Lee L, Uchida M, Takayanagi R. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol 2013; 19(1): 35-41 [PMID: 23326160 DOI: 10.3748/wjg.v19.i1.35] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]